0268-0279 : Timothy, Standardized 100000 [bau]/Ml Subcutaneous Injection, Solution


NDC: 0268-0279
Labeler: Alk-abello, Inc.
Product Type: Human Prescription Drug
Drug Name: Timothy, Standardized
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA103058
Rev. Date: 


NDC Package Codes:

  • 0268-0279-10: 10 ML IN 1 VIAL, MULTI‑DOSE (0268‑0279‑10)
  • 0268-0279-50: 50 ML IN 1 VIAL, MULTI‑DOSE (0268‑0279‑50)

Active Ingredients:

  • Phleum Pratense Pollen

Dosage Strength:

  • 100000 [BAU]/mL

Pharmaceutical Classes:

  • Allergens [CS]
  • Cell-mediated Immunity [PE]
  • Increased Histamine Release [PE]
  • Increased IgG Production [PE]
  • Pollen [CS]
  • Standardized Pollen Allergenic Extract [EPC]

Related Products:

Based on records with the same trade name.
  • 0268-0280 Timothy, Standardized 10000 [bau]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-3063 Timothy, Standardized 100000 [bau]/Ml Percutaneous Solution by Alk-abello, Inc.
  • 0268-3064 Timothy, Standardized 10000 [bau]/Ml Percutaneous Solution by Alk-abello, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0268-0279 QR Code

< Prev: 0268-0278Next: 0268-0280 >

Related Discussions:

pollen-eze hay fever tablets
can anyone please help, i had a severe reaction to pollen-eze hay fever tablets a few years ago, i want to know what the... 2 replies
Loss of voice due to pollen allergies
I have been on Betamax 875mg plus 125mg twice a day. How long will it take to cure the loss of voice due to allergies? #... 1 reply
rye pollen extract
Can I take finasteride and prostabrit [rye pollen extract] togther?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.